5.0
Feb 21, 2019
Current employee, more than 1 year
Paris
Recommend
CEO approval
Business Outlook
Pros
Global and inclusive organization Amazing sales growth for the past two years Biotech mindset Great programs as ESPP and free shares for all Becoming oncology leader R&D presence via Oxford, Cambridge (US) and Paris Saclay hubs
Cons
Need to be even more agile despite its growing size Not yet well known employer brand